ClinicalMetric / Countries / Finland / inflammation
← 🇫🇮 Finland Trials
🇫🇮 Finland Country × Condition

inflammation Clinical Trials in Finland

Active clinical trials for inflammation with research sites in Finland. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 1 // Recruiting: 1 // Updated: Daily
Total Trials
1
Recruiting Now
1
Country
🇫🇮 Finland

Active Trials in Finland (1)

NCT07877324
Recruiting

Vascular Inflammation in Atherosclerosis - Whole Body Molecular PET/CT Imaging Using Folate Receptor β

Enrollment
90 pts
Country
🇫🇮 Finland
Turku University Hospital
View Trial →

Frequently Asked Questions

How many inflammation clinical trials are active in Finland?
There are currently 1 active clinical trials for inflammation with sites in Finland, of which 1 are actively recruiting patients.
How can I join a inflammation clinical trial in Finland?
To join a inflammation clinical trial in Finland, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Finland directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are inflammation trials in Finland?
Active inflammation trials in Finland span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Finland Trials → Global inflammation Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology